Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (231-240 of 375) with videos related to

Pageof 38
Sort By:
Oncotarget|January 22, 2017
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational studyClaudia Bighin, Beatrice Dozin, Francesca Poggio, et al.
Breast Cancer Research and Treatment|October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trialsEvandro de Azambuja, Noam Ponde, Marion Procter, et al.
Journal of Geriatric Oncology|August 3, 2020
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 - EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measuresIcro Meattini, Philip M P Poortmans, Livia Marrazzo, et al.
AIDS (London, England)|January 4, 2021
Impact of HIV infection on baseline characteristics and survival of women with breast cancerMariana Brandão, Marco Bruzzone, Maria-Alice Franzoi, et al.
Expert Opinion on Pharmacotherapy|January 5, 2024
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?Diletta Favero, Laura Sabina Lapuchesky, Francesca Poggio, et al.
Cancer|December 1, 2020
Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancerPhilip D Poorvu, Shari I Gelber, Yue Zheng, et al.
Journal of the National Cancer Institute|April 4, 2026
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trialElisa Agostinetto, Gabriella Gentile, Faye Samy, et al.
In Vivo (Athens, Greece)|January 6, 2021
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care WorkersPiero Fregatti, Marco Gipponi, Maria Giacchino, et al.
Journal of the National Cancer Institute|August 5, 2020
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine TherapyMaria Alice Franzoi, Daniel Eiger, Lieveke Ameye, et al.
Journal of the National Cancer Institute|November 1, 2017
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor StatusMatteo Lambertini, Niels Kroman, Lieveke Ameye, et al.
Pageof 38

Showing results (231-240 of 375) with videos related to

Sort By:
Pageof 38
Oncotarget|January 22, 2017
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational studyClaudia Bighin, Beatrice Dozin, Francesca Poggio, et al.
Breast Cancer Research and Treatment|October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trialsEvandro de Azambuja, Noam Ponde, Marion Procter, et al.
Journal of Geriatric Oncology|August 3, 2020
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 - EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measuresIcro Meattini, Philip M P Poortmans, Livia Marrazzo, et al.
AIDS (London, England)|January 4, 2021
Impact of HIV infection on baseline characteristics and survival of women with breast cancerMariana Brandão, Marco Bruzzone, Maria-Alice Franzoi, et al.
Expert Opinion on Pharmacotherapy|January 5, 2024
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?Diletta Favero, Laura Sabina Lapuchesky, Francesca Poggio, et al.
Cancer|December 1, 2020
Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancerPhilip D Poorvu, Shari I Gelber, Yue Zheng, et al.
Journal of the National Cancer Institute|April 4, 2026
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trialElisa Agostinetto, Gabriella Gentile, Faye Samy, et al.
In Vivo (Athens, Greece)|January 6, 2021
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care WorkersPiero Fregatti, Marco Gipponi, Maria Giacchino, et al.
Journal of the National Cancer Institute|August 5, 2020
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine TherapyMaria Alice Franzoi, Daniel Eiger, Lieveke Ameye, et al.
Journal of the National Cancer Institute|November 1, 2017
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor StatusMatteo Lambertini, Niels Kroman, Lieveke Ameye, et al.
Pageof 38